CFDE Data Portal | Search ASS1P11

	Label	Description
	ASS1P11 associations Collection (Entity type)	Associations for ASS1P11_associations
	ASS1P11 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ASS1P11 Gene (Entity type)	ENSG00000225308 - argininosuccinate synthetase 1 pseudogene 11
	GSE103567 EZH2 inhibition 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE162892 ISOX 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178975 GSE178978 EGFR inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE152246 dihydrotestosterone 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE162892 ISOX 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GPR39 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	WEE2 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

ASS1P11 associations

Associations for ASS1P11_associations

ASS1P11 associations.tsv

A file from IDG as part of the Harmonizome project

ASS1P11

ENSG00000225308 - argininosuccinate synthetase 1 pseudogene 11

GSE103567 EZH2 inhibition 5 v 2 human dn

A Gene Set from LINCS

GSE162892 ISOX 3 v 1 human up

A Gene Set from LINCS

GSE178975 GSE178978 EGFR inhibition 1 v 0 human up

A Gene Set from LINCS

GSE152246 dihydrotestosterone 0 v 1 human dn

A Gene Set from LINCS

GSE162892 ISOX 3 v 5 human up

A Gene Set from LINCS

GPR39 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

WEE2 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.